Managing bleeding in patients on Direct Oral Anticoagulants (DOACs) requires a rapid and informed approach. This module provides guidance on identifying DOAC-related bleeds, selecting appropriate reversal strategies, and balancing the risks of thromboembolism. It covers both specific and non-specific reversal agents, laboratory testing considerations, and practical steps for emergency and non-emergency situations, ensuring you can make evidence-based decisions when treating DOAC-associated bleeding.
Effective warfarin reversal is a critical aspect of bleeding management, requiring timely and evidence-based decision-making. This module answers key clinical…
Enroll NowThe massive hemorrhage protocol (MHP) is a clinical pathway that brings together the right patient, right team, and right interventions…
Enroll NowThis module focuses on the role of Prothrombin Complex Concentrates (PCC) and Fibrinogen Concentrate (FC) in managing bleeding during cardiac…
Enroll Nowtreatthebleed©2026